Razionale
Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disease of motor neurons with a dramatic socio-economic impact on the national health system. It is characterized by high genetic heterogeneity, with more than 30 causative genes accounting for 60% of familial and 10% of sporadic cases.
A variety of biomarkers, including neurofilaments and extracellular vesicles, hold great promise in predicting the development of ALS and the variability in its progression.
Neuroimaging techniques have demonstrated to be able to detect abnormalities in motor and non-motor areas with a variety of patterns that reflect disease severity, progression, and duration.
All these points of views have been investigated in the PERMEALS project to drive research toward personalized medicine, including a team of exceptional and specific expertise in all these aspects of ALS research. The results of this project could represent the first step toward a personalized medicine to cure ALS.
Segreteria Scientifica
Scientific Committee
Prof. Andrea Calvo • Dott. AntonioCanosa • Prof. Adriano Chiò
A.O.U. Città della Salute e della Scienza, CreSLA – Torino
Prof. Nicola Ticozzi • Prof.ssa Antonia Ratti
IRCCS Istituto Auxologico Italiano – Milano
Dott.ssa Valentina Bonetto • Dott.ssa Laura Pasetto
IRCCS Istituto Mario Negri – Milano
Prof.ssa Francesca Trojsi
A.O.U. Università della Campania “Luigi Vanvitelli – Napoli
Informazioni generali ECM
La partecipazione al convegno è riservata, esclusivamente, ai medici chirurghi in formazione c/o la Scuola di Specializzazione di Neurologia dell’A.O.U. Università della Campania “Luigi Vanvitelli.
Sede del Convegno
Complesso Monumentale Santa Maria la Nova
Piazza S. Maria la Nova, 44, 80134 Napoli NA
Link indicazioni Google Maps: https://maps.app.goo.gl/5raG3zUChsJjWWXz6